(02) 9926 4726

News and Event

Sydney Vital Seed Funding – Closed

Sydney Vital is pleased to invite applications for its Seed Funding Awards to the value of $25,000 each. The Sydney Vital Seed Funding Scheme intends to seed new ideas, with the goal of generating data to a point where external funding may be sought. The ideas to be tested should be (i) new in concept and (ii) distinct from currently or previously funded research. Projects should focus on Translational Cancer Research and closely align with one or more of Sydney Vital’s Flagship Programs and/or Translational Cancer Research Centres (TCE) which are;

Flagships

Inflammation
Translational Theranostics
Nanotechnology

TCEs

Pancreatic Cancer
Thyroid Cancer
Breast Cancer Implementation
Neuroendocrine Tumours
Glioblastoma
Sydney 1000 CRC
Adrenocortical Cancer

 

Key Dates

Call for Applications: 14 February 2018

Closing Date for Applications: 9th March 2018

 

Useful Documents:

Sydney Vital_Seed Funding Award_Guidelines_Feb 2018

SV_Seed Funding_Application Form_Feb 2018

Any queries should be directed to [email protected]

Read more

Funding Awarded By Sydney Vital

The research projects below were awarded by Sydney Vital. We will post their progress when it is submitted and to keep up-to-date with our scholarships, funding and awards, check out our grant schemes.

#AwardeeInstitutionSupervisorResearch TitleAmount
Awarded
1Jerikho BulanadiKolling Institute of Medical ResearchProf Ross SmithChemotherapeutic prodrugs incorporated within recombinant high density lipoprotein nanoparticles as a modality of targeted delivery.$15,000
2Emma ColvillSydney University Medical SchoolProf Paul KeallThe bench-to-bedside clinical implementation of real-time targeted radiotherapy for prostate cancer$15,000
3Grace GiffordHaematology and Anatomical Pathology Departments. Royal North Shore Hospital, St Leonards, SydneyDr William StevensonGene expression profiling of high grade B-cell lymphomas with NanoString nCounter technology. Validation of a novel diagnostic platform and implementation into clinical use for prognostication and therapeutic decision-making.$15,000
4Dr Anthony GloverKolling Institute of Medical Research, Royal North Shore HospitalProf Stanley SidhuNoncoding RNAs as tumour suppressors in adrenal cancer: Unlocking the mechanisms to improve patient outcomes.$15,000
5Diana HatoumFaculty of Science, UTS SydneyDr Najah NassifA Role for p14ARF-p53 in Treatment Resistance and Recurrence in Hormone-dependent Breast Cancer.$15,000
6Samuel BrennanFaculty of Science, UTS SydneyDr Rose Martiniello-WilksDevelopment of a non-invasive liquid biopsy for prostate cancer: Identification of unique exosome microRNA (exomiR) signatures in patient body fluids for cancer diagnosis and prognosis.$15,000
7Ben HarrisSydney Medical School, University of SydneyDr Kellie CharlesInvestigating mechanisms of chemoresistance to platinum drugs mediated by systemic inflammation.
$15,000
8Adrian LeeBill Walsh Translation Cancer Research Laboratory, Kolling InstituteDr Viive Howell"Do molecular aberrations in the tumour predict for venous thrombotic episodes in patients with
glioblastoma multiforme?"
$15,000
9Jaynish ShahSydney Medical School, University of SydneyProf Deborah MarshInvestigating the complexity of p53 pathways in ovarian cancer: are non-coding RNAs the key?$15,000
Read more

Rectal Cancer: Question Time

New Paradigms in Rectal Cancer

 

Read more

Implementation Research Pilot projects – CLOSED

CALL FOR EOI’S

Sydney Vital is calling for proposals for implementation research pilot projects via an Expression of Interests (EOI) process.
Sydney Vital will provide financial support for a number of implementation research projects in the 2015 calendar year.

This expression of interest (EOI) may include (but are not limited to) the following themes:
• Educate Sydney Vital member network on implementation (T3) of evidence based supportive care strategies for cancer symptoms and treatment side effects.
• Develop Health Professional Education modules using e-learning techniques which can be made available to clinicians in NSW.
• Identify new clinical pathways or techniques based on the evidence based guidelines suitable for implementation
• Test methods for delivery of psychosocial support and reduction of treatment toxicity
• Evaluating new approaches to breast reconstruction and their impact on Quality of Life (QoL).
• Identify ways to improve management of survivorship issues in cancer patients.
• Test new methods of care or prognostic factors for patients with late stage cancer.

FUNDING AVAILABLE
Up to $25,000 in funding to support the undertaking of an implementation research project. The funding must be spent within 12 months of receiving the award. Management team may allocate funding to one or more projects.

Read More: Implementation Research_Seed Funding 2015_EOI
Closing Date for EOI’s: Friday, 5 June 2015

Read more

PET/CT scanning in Lung Cancer

Read more

2013 NSW Health Innovation Symposium: Connecting Minds

– Translating Research Into Care
Presented by Professor Robyn Ward

The 2013 NSW Health Innovation Symposium featured 63 presentations on ground-breaking health initiatives that harness new ideas, new technologies and new approaches to the delivery of patient care.

Read more